In the latest episode of One in Two: A Manchester Cancer Research Podcast, we speak to Professor Matt Evison, Professor of Thoracic oncology, and never-smoker ALK+ lung cancer patient, Sally Hayton about: · Never-smoker lung cancer sympto

Bonus

Breast cancer in Black African women with Professor David Wedge: How analysing genomics can improve our understanding of the aggressiveness of breast cancer

Mar 4th, 2024 58m 44s

In this episode, we speak to Professor David Wedge, Professor of Cancer Genomics and Data Science, about breast cancer in Black African women, focussing on: · Cancer genomics and what we understand ethnicity to be in the context of genomi

Hereditary cancer predisposition with Dr Emma Woodward and patient Nick Brown: How can the ATLAS study improve cancer early detection in carriers of Li Fraumeni Syndrome?

Jan 23rd, 2024 52m 45s

In this episode, we speak to Dr Emma Woodward and patient Nick Brown, about hereditary cancer predisposition, focusing on: · Li Fraumeni Syndrome (LFS), a rare cancer predisposing condition which gives a 70% lifetime risk of developing

One in Two - Clinical trials with Professor Corinne Faivre-Finn: How RAPID RT could improve survival rates for lung cancer patients

Sep 11th, 2023 56m 9s

In this episode, we speak to Corinne Faivre-Finn, a Professor of Thoracic Radiation Oncology about lung cancer clinical trials, focussing on: · Radiotherapy: what it is and how it’s used to treat lung cancers · Clinical trials: wha

One in Two Podcast - Lung Cancer in never smokers with Dr Fabio Gomes: The ALK positive mutation in Non-Small Cell Lung Cancer (NSCLC)

Aug 15th, 2023 55m 57s

In this episode, we speak to Dr Fabio Gomes, a Consultant Medical Oncologist at The Christie NHS Foundation Trust, about lung cancer in never smokers, focusing on: The commonality of lung cancer in never smokers Why never smokers are susceptib

Cancer biomarkers with Professor Caroline Dive: How liquid biopsies could pave the way for lung cancer detection and treatment

Jul 31st, 2023 1h 2m

In this episode, we speak to Professor Caroline Dive, Professor of Cancer Pharmacology at The University of Manchester, Interim Director of the Cancer Research UK Manchester Institute and Director of the CRUK Cancer Biomarker Centre, about can

One in Two podcast - The basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation

Jun 9th, 2023 1h 11m

In this episode, we speak to Dr Colin Lindsay, Clinical Senior Lecturer at The Christie and The University of Manchester about the basic biology of lung cancer, focusing on: The high incidence of lung cancer here in Manchester The difference

One in Two podcast – Screening access challenges with Dr Jen Davies-Oliveira and Stewart O’Callaghan: How to improve cancer screening uptake in the LGBTQIA+ community and other marginalised groups

Apr 17th, 2023 1h 5m

In this special episode, we speak to Dr Jen Davies-Oliveira, a researcher and PhD student at The University of Manchester and Stewart O’Callaghan, the Founder and Chief Executive of Live Through This, the UK’s only LGBTQIA+ Cancer charity. We

Prostate cancer with Professor Robert Bristow: Is globalisation the future of cancer research?

Feb 3rd, 2023 1h 9m

This World Cancer Day 2023, we speak to Professor Robert Bristow, the Director of the Manchester Cancer Research Centre, Chief Academic Officer at The Christie NHS Foundation Trust and Professor of Cancer Studies at The University of Manchester

One in Two podcast - Looking outside the cell with Professor Sarah Cartmell: can we see where cancer starts?

Nov 11th, 2022 35m 34s

In this episode we speak to Professor Sarah Cartmell on her work in bioengineering and ex-vivo modelling which involves studying cancer cells outside of an organism.Specifically, we talk about her team's work developing these models that can an

One in Two podcast - Womb cancer and Lynch syndrome with Professor Emma Crosbie: How did we change clinical practice?

Nov 4th, 2022 40m 23s

In this episode, we speak to Professor Emma Crosbie about her research in womb cancer and the breakthrough she made in discovering a link between Lynch syndrome and womb cancer.We discuss the steps Emma and her team took to change NICE guidance

One in Two podcast - Nano-omics with Dr Marilena Hadjidemetriou: can nanoparticles help us find early signs of cancer?

Oct 28th, 2022 23m 52s

In this episode we speak to Dr Marilena Hadjidemetriou about her research on nano-omics, which aims to integrate nanotechnology to the ‘world of omics’ as well as proteomic biomarker discovery.We find out how nano-omics is being used to isolate

One in Two podcast - Health Economics: Is early detection cost effective?

Oct 14th, 2022 49m 30s

In this episode we speak to Professor Katherine Payne about health economics; what it is, its importance in cancer treatment and early detection strategies and the crucial role it plays in changing healthcare policy.We discuss Katherine’s work

One in Two podcast - Cervical screening in the LGBTQIA+ community with Dr Jen Davies-Oliveria and Professor Emma Crosbie: how can we make screening more inclusive?

Oct 7th, 2022 42m 37s

In this episode we speak to Dr Jen Davies-Oliveira and Professor Emma Crosbie about their research into womb cancer and human papilloma virus, commonly known as HPV. We also discuss one of their research projects developing alternative self-sam

One in Two podcast - Breast cancer with Professor Gareth Evans: should all women be screened equally?

Sep 29th, 2022 41m 55s

In this episode we speak to Professor Gareth Evans about the importance of breast cancer screening, as well as the risk predictors of breast cancer as he answers the question: Should all women be screened equally for breast cancer? He discusses

One in Two podcast - Health inequalities with Professors Phil and Emma Crosbie: does going directly to communities improve screening uptake?

Sep 22nd, 2022 38m 29s

In this episode, we speak to Professor Phil Crosbie and Professor Emma Crosbie about their research in the early detection of lung and womb cancer and their work on community screening and addressing health inequalities.With cancer incidence ri

Rate